Yeast protein could offer clues to how Alzheimer's plaques form in the brain

by Anne Trafton,Massachusetts Institute of TechnologyMIT biologists found that the yeast protein Rim4 forms disordered clumps similar to the beta-amyloid plaques associated with Alzheimer’s dise

Updated on: February 26,2024

Yeast protein could offer clues to how Alzheimer's plaques form in the brain

by Anne Trafton,Massachusetts Institute of TechnologyMIT biologists found that the yeast protein Rim4 forms disordered clumps similar to the beta-amyloid plaques associated with Alzheimer’s dise

Updated on:February 26,2024

Daytime sleepiness linked to Alzheimer's

by From Mayo Clinic News Network, Mayo Clinic News NetworkPET scan of a human brain with Alzheimer's disease. Credit: public domainDo you catch yourself yawning during the day and yearning for an

Updated on: April 25,2024

Daytime sleepiness linked to Alzheimer's

by From Mayo Clinic News Network, Mayo Clinic News NetworkPET scan of a human brain with Alzheimer's disease. Credit: public domainDo you catch yourself yawning during the day and yearning for an

Updated on:April 25,2024

Tau does not stabilize microtubules, challenges approach to treating Alzheimer's

by Drexel UniversityThis image represents the role of tau and MAP6 in regulating the stable (green) and dynamic (red) parts of a neuron's microtubules. Depleting tau from cultured rat neurons

Updated on: April 02,2024

Tau does not stabilize microtubules, challenges approach to treating Alzheimer's

by Drexel UniversityThis image represents the role of tau and MAP6 in regulating the stable (green) and dynamic (red) parts of a neuron's microtubules. Depleting tau from cultured rat neurons

Updated on:April 02,2024

Global study could change how children with multiple sclerosis are treated

by Melbourne HealthCredit: CC0 Public DomainA new study—the largest of its kind globally—has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-ef

Updated on: March 28,2024

Global study could change how children with multiple sclerosis are treated

by Melbourne HealthCredit: CC0 Public DomainA new study—the largest of its kind globally—has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-ef

Updated on:March 28,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on: April 16,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on:April 16,2024

7T brain scans reveal potential early indicator of Alzheimer's

by Center for BrainHealthCredit: Unsplash/CC0 Public DomainResearchers from the Center for BrainHealth at The University of Texas at Dallas are investigating a potential new early indicator of the dec

Updated on: March 13,2024

7T brain scans reveal potential early indicator of Alzheimer's

by Center for BrainHealthCredit: Unsplash/CC0 Public DomainResearchers from the Center for BrainHealth at The University of Texas at Dallas are investigating a potential new early indicator of the dec

Updated on:March 13,2024

Routine brain scanning may improve clinical care for people with psychosis

by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc

Updated on: February 05,2024

Routine brain scanning may improve clinical care for people with psychosis

by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc

Updated on:February 05,2024

Preliminary study: Drug may be safe in those with mild cognitive impairment, mild dementia

by American Academy of NeurologyCredit: CC0 Public DomainA small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Al

Updated on: February 05,2024

Preliminary study: Drug may be safe in those with mild cognitive impairment, mild dementia

by American Academy of NeurologyCredit: CC0 Public DomainA small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Al

Updated on:February 05,2024

Combining cell therapy with approved drug shows promise for treating multiple sclerosis

byJosep Carreras Leukaemia Research InstituteCredit: Pixabay/CC0 Public DomainMultiple sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer aroun

Updated on: October 14,2024

Combining cell therapy with approved drug shows promise for treating multiple sclerosis

byJosep Carreras Leukaemia Research InstituteCredit: Pixabay/CC0 Public DomainMultiple sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer aroun

Updated on:October 14,2024

A new study shows how neurochemicals affect fMRI readings

byUniversity of North Carolina Health CareStimulus-evoked negative fMRI signals in striatum. Credit: Yen-Yu Ian Shih, Ph.D.The brain is an incredibly complex and active organ that uses electrici

Updated on: March 28,2024

A new study shows how neurochemicals affect fMRI readings

byUniversity of North Carolina Health CareStimulus-evoked negative fMRI signals in striatum. Credit: Yen-Yu Ian Shih, Ph.D.The brain is an incredibly complex and active organ that uses electrici

Updated on:March 28,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on: June 20,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on:June 20,2024

Panel of 48 CSF proteins complements existing Alzheimer biomarkers

by Elana GotkineA panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of&

Updated on: March 02,2024

Panel of 48 CSF proteins complements existing Alzheimer biomarkers

by Elana GotkineA panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of&

Updated on:March 02,2024